Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, September 8, 2021
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Tue, September 7, 2021
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Matthew Harrison Downgraded (AMGN) to Hold and Decreased Target to $251 on, Sep 7th, 2021
Matthew Harrison of Morgan Stanley, Downgraded "Amgen Inc." (AMGN) to Hold and Decreased Target from $280 to $251 on, Sep 7th, 2021.
Matthew has made no other calls on AMGN in the last 4 months.
There are 2 other peers that have a rating on AMGN. Out of the 2 peers that are also analyzing AMGN, 1 agrees with Matthew's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Geoffrey Porges of "SVB Leerink" Maintained at Hold with Decreased Target to $234 on, Wednesday, August 4th, 2021
This is the rating of the analyst that currently disagrees with Matthew
- Jay Olson of "Oppenheimer" Maintained at Buy with Increased Target to $277 on, Monday, June 7th, 2021
